| Literature DB >> 25424960 |
Patricia Kaaijk1, Deborah E Kleijne, Mirjam J Knol, Irene A Harmsen, Olga J A E Ophorst, Nynke Y Rots.
Abstract
Last decades, the number of routine childhood vaccinations has increased considerably, which consequently has led to multiple vaccine injections per consultation. Implementation of additional vaccines will probably lead to more than 2 vaccine injections per consult, which might be a barrier for parents to vaccinate their child. A decrease in vaccination coverage, however, increases the risk of disease outbreaks. Less stressful alternative methods for vaccine delivery might lead to an increased acceptance of multiple childhood vaccinations by parents. The present questionnaire study was set up to explore the maximum number of vaccine injections per visit that is acceptable for parents, as well as to gauge parents' attitude toward alternative needle-free methods for vaccine delivery. For this purpose, the parents' opinion toward a jet injector, a patch, a microneedle system, and nasal spray device as methods for vaccine delivery was assessed. The majority of the 1154 participating parents indicated that 3 vaccine injections per visit was perceived as too much. Most participants had a positive attitude with respect to the jet injector and the patch as alternative vaccine delivery method, whereas the microneedle device and an intranasal spray device were not perceived as better than the conventional syringe by the parents. Parents indicated that both the jet injector and the patch might increase their acceptance of giving their children more than 2 vaccinations at the same time. This should encourage vaccine developers and manufacturers to put efforts in developing these delivery methods for their vaccines.Entities:
Keywords: Parents’ attitude; alternative delivery methods; childhood routine vaccinations; jet injector; microneedle device; nasal spray device; patch; questionnaire
Mesh:
Substances:
Year: 2014 PMID: 25424960 PMCID: PMC4896758 DOI: 10.4161/hv.29361
Source DB: PubMed Journal: Hum Vaccin Immunother ISSN: 2164-5515 Impact factor: 3.452
Table 1. Vaccination schedule of the national immunization program of the Netherlands (at the time of performing this questionnaire study)
| Age | Injection 1 | Injection 2 |
|---|---|---|
| At birth (<48 h) | HBVa | |
| 6–9 wk | DTaP-HBV-IPV/Hib | Pneumo |
| 3 mo | DTaP-HBV-IPV/Hib | Pneumo |
| 4 mo | DTaP-HBV-IPV/Hib | Pneumo |
| 11 mo | DTaP-HBV-IPV/Hib | Pneumo |
| 14 mo | MMR | MenC |
| 4 y | DTaP-IPV | |
| 9 y | DT-IPV | MMR |
| 12 y | HPVb |
a Only for children of whom the mother tested positive for HBsAg;b Only for girls; 3 doses at 0 d, 1 mo, and 6 mo. Abbreviations: HBV, Vaccine against hepatitis B virus; DTaP-HBV-IPV/Hib, Combination vaccine with diphtheria toxoid, tetanus toxoid, acellular pertussis, hepatitis B virus, inactivated poliomyelitis virus, and Hemophilus influenzae serotype b component; Pneumo, Pneumococcal vaccine; MMR, Measles, mumps, rubella vaccine; MenC, Vaccine against meningococcal serogroup C disease; DTaP-IPV, Combination vaccine with diphtheria toxoid, tetanus toxoid, acellular pertussis, and inactivated poliomyelitis virus; DT-IPV, Combination vaccine with diphtheria toxoid, tetanus toxoid, and inactivated poliomyelitis virus; HPV, Vaccine against human papillomavirus.
Table 2. Demographic characteristics of the 1154 participants
| Characteristic | % (n) | % (n) | |||
|---|---|---|---|---|---|
| Female | 86% (990) | ||||
| Male | 14% (164) | ||||
| Mean: 37.2 y, SD 7.5 y | |||||
| <19 y | 0.3 (3) | ||||
| 19–29 y | 15 (171) | ||||
| 30–39 y | 45 (518) | ||||
| 40–49 y | 37 (428) | ||||
| ≥50 y | 3 (34) | ||||
| 1 | 22% (250) | ||||
| 2 | 50% (578) | ||||
| 3 | 21% (245) | ||||
| >4 | 7% (81) | ||||
| <1 y | 35% (401) | <1 y | 16% (179) | ||
| 1–3 y | 10% (119) | 1–3 y | 9% (106) | ||
| 4–8 y | 25% (285) | 4–8 y | 24% (277) | ||
| 9–11 | 20% (229) | 9–11 y | 20% (225) | ||
| >12 y | 10% (120) | >12 y | 32% (367) | ||
| The Netherlands | 94% (1087) | ||||
| Suriname | 1% (11) | ||||
| The Netherlands Antilles and Aruba | 0.6% (7) | ||||
| Turkey | 0.3% (3) | ||||
| Morocco | 0.3% (3) | ||||
| Other | 4% (43) | ||||
| The Netherlands | 92% (1062) | ||||
| The Netherlands | 91% (1050) | ||||
| Below average | 9% (102) | ||||
| Average | 24% (278) | ||||
| Above average | 41% (474) | ||||
| Not answered | 26% (300) | ||||
| Lower level | 7% (79) | ||||
| Intermediate level | 42% (477) | ||||
| Higher level | 50% (572) | ||||
| Not answered | 2% (26) | ||||
Lower educational level was defined as the highest level of education being primary school, junior secondary technical school, or intermediate secondary education. Intermediate educational level was defined as the highest level of education being intermediate vocational education, higher secondary education, pre-university education. Higher educational level was defined as the highest level of education being higher vocational education and university.
Table 3. The solicited advantages or disadvantages for the intention to receive more than 2 vaccine injections per visit were listed in order of highest to lowest mean scores (n = 1154)
| Items | Mean (SD) | |
|---|---|---|
| Receiving 3 vaccine injections at one visit is more convenient, because it results in less stress than an extra visit | 3.23 (2.00) | |
| Receiving 3 vaccine injections at one visit is more preferable, since there is only one moment for the risk of side effects | 3.51 (2.00) | |
| Receiving more than 2 vaccine injections at one visit is not preferred, because detection of adverse events per vaccine is impossible | 5.37 (1.51) | |
| Receiving more than 2 vaccine injections at one visit is not preferred, because it is too much to process for my child’s body | 4.90 (1.65) | |
| Receiving more than 2 vaccine injections at one visit is not preferred, because it the physical load is too high for my child | 4.82 (1.75) | |
| Receiving more than 2 vaccine injections at one visit is not preferred, because the risk of more (serious) adverse events is too high | 4.80 (1.68) | |
| Receiving more than 2 vaccine injections at one visit is not preferred, because it is too stressful for my child | 4.54 (1.99) | |
| Receiving more than 2 vaccine injections at one visit is not preferred, because it is not good for my child’s immune system | 4.29 (1.69) |
Table 4. Mean scores of parents for the intention to receive more than 2 vaccine injections per consultation, per age group of the child
| If 3 vaccine injections were offered, | All parents | Only parents that | |
|---|---|---|---|
| Mean (SD) | |||
| 3.60 (2.13) | n.a* | n.a.* | |
| 4.01 (2.06) | 4.57 (1.93) | 3.83 (2.06) | |
| 4.47 (2.08) | 4.73 (2.00) | 4.22 (2.12) | |
| 4.71 (2.09) | 4.83 (2.03) | 4.44 (2.19) | |
The intention to receive more than 2 vaccine injections per visit among all parents was lowest for children below 1 y of age, followed by children aged 4, 9, and 12 y-olds resp. (all differences were statistically significant; P < 0.001); Scores for parents that have or had children in the age of 4, 9, or 12 y were significantly lower than parents that had only younger children (p-value were resp. P < 0.001; P < 0.001, P = 0.003); *All parents have or had children aged <1 y, i.e., inclusion criterium.
Table 5. Mean scores of parents’ perception of suitability of the various vaccine delivery methods to vaccinate their child at specific age
| Mean scores (SD) | |||||
|---|---|---|---|---|---|
| Jet injector | Patch | Microneedles | Intranasal spray | ||
| 6.03 (1.17) | 5.40 (1.69) | 4.03 (1.76) | 3.86 (2.06) | ||
| 5.10 (1.64) | 3.66 (2.07) | 3.55 (1.76) | 2.65 (1.88) | ||
| 5.40 (1.47) | 3.90 (2.00) | 3.88 (1.72) | 2.85 (1.85) | ||
| 5.57 (1.42) | 4.92 (1.80) | 4.35 (1.72) | 4.32 (2.05) | ||
| 5.59 (1.44) | 5.22 (1.71) | 4.46 (1.73) | 4.73 (2.02) | ||
All comparisons among age groups are statistically significant with the exception of the opinion on the jet injector for 9 vs. 12-y-olds